ANI Pharmaceuticals Inc (ANIP)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 3.00 | 2.99 | 2.02 | 2.02 | 2.09 | 1.96 | 1.98 | 2.25 | 2.25 | 2.20 | 2.23 | 2.15 | 2.15 | 2.46 | 2.50 | 2.28 | 2.36 | 2.37 | 2.43 | 2.40 |
ANI Pharmaceuticals Inc has consistently maintained a strong solvency position, as indicated by its solvency ratios. The debt-to-assets, debt-to-capital, and debt-to-equity ratios have all remained at 0.00 over the period analyzed, reflecting that the company has no debt relative to its assets, capital, or equity.
Additionally, the financial leverage ratio has shown some fluctuations but generally stayed close to the 2.00 range. This indicates that ANI Pharmaceuticals has maintained a moderate level of financial leverage over the period, suggesting a balanced mix of debt and equity in its capital structure.
Overall, the solvency ratios suggest that ANI Pharmaceuticals Inc has a solid financial foundation with a low level of debt, which bodes well for its long-term financial stability and ability to meet its financial obligations.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | -0.73 | 0.21 | 2.23 | 2.18 | 1.74 | 1.49 | 0.92 | 0.12 | -0.89 | -2.13 | -2.81 | -3.33 | -2.73 | -0.87 | -0.15 | -0.58 | -1.70 | -2.19 | -1.57 | 0.35 |
ANI Pharmaceuticals Inc's interest coverage ratio shows the company's ability to cover its interest expenses with its operating income. The data indicates that the company's interest coverage ratio was negative for the periods between March 31, 2020, and December 31, 2022, which suggests that ANI Pharmaceuticals struggled to generate enough operating income to cover its interest expenses during these periods.
However, starting from March 31, 2023, the interest coverage ratio turned positive and gradually improved over the subsequent quarters. This improvement is a positive sign as it indicates that the company's operating income became sufficient to cover its interest expenses, reducing the financial risk associated with servicing its debt obligations.
Overall, the trend in ANI Pharmaceuticals Inc's interest coverage ratio shows a progression from negative to positive values, signaling an improvement in the company's financial health and its ability to manage its interest expenses effectively.